1. Jame, S., & Barnes, G. (2020). Stroke and thromboembolism prevention in atrial fibrillation. Heart (British Cardiac Society), 106(1), 10–17. https://doi.org/10.1136/heartjnl-2019-314898
2. Bonnemeier H, Huelsebeck M, Kloss S. Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany—A retrospective cohort study. IJC Heart & Vasculature. 2019 Jun 1;23:100367. https://www.sciencedirect.com/science/article/pii/S2352906718301702
3. Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, et al. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. New England Journal of Medicine. 2023 Nov 12. https://doi.org/10.1056/NEJMoa2310234
4. Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MS, et al, American Heart Association Council on Clinical Cardiology Electrocardiography and Arrhythmias Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Subclinical and device-detected atrial fibrillation: pondering the knowledge gap: a scientific statement from the American Heart Association. Circulation. 2019 Dec 17;140(25):e944-63. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000740
5. Ballatore A, Matta M, Saglietto A, Desalvo P, Bocchino PP, et al. Subclinical and asymptomatic atrial fibrillation: current evidence and unsolved questions in clinical practice. Medicina. 2019 Aug 18;55(8):497. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722728/
6. Wu J, Zhang Y, Liao X, Lei Y. Anticoagulation therapy for non-valvular atrial fibrillation: a mini-review. Frontiers in medicine. 2020 Jul 21;7:350. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396601/
7. Kreimer F, Mügge A, Gotzmann M. How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance. Clinical Research in Cardiology. 2022 Sep;111(9):994-1009. https://link.springer.com/article/10.1007/s00392-022-02000-7
8. Cuadrado‐Godia E, Benito B, Ois A, Vallès E, Rodríguez‐Campello A, et al. Ultra‐early continuous cardiac monitoring improves atrial fibrillation detection and prognosis of patients with cryptogenic stroke. European Journal of Neurology. 2020 Feb;27(2):244-50. https://doi.org/10.1111/ene.14061
9. Perino AC, Fan J, Askari M, Heidenreich PA, Keung E, et al. Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation: insights from the veterans health administration. Circulation. 2019 May 28;139(22):2502-12. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038988
10. Sandgren E, Rorsman C, Edvardsson N, Engdahl J. Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation. PloS one. 2018 Sep 13;13(9):e0203661. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0203661